Abstract
A directing-group-on-leaving-group strategy (DGLG) was applied to stereospecific synthesis of 2-deoxy-2-fluoroglycosides via SN2 glycosylation. This strategy utilized 2-deoxy-2-fluoroglycosyl donors featuring a chromenone-based leaving group, which is activated rapidly under exceedingly mild conditions to achieve complete stereochemical inversion at the donor anomeric position. This method readily applies to 2-deoxy-2-fluoroglucose, 2-deoxy-2-fluorogalactose, 2,6-dideoxy-2-fluoroglucose, 2-deoxy-2-fluoroarabinose, and 2-deoxy-2-fluororibose, delivering high yields and complete stereochemical inversion, despite the presence of a neighboring deactivating fluoro group and the potential adverse fluorine directing effect. This method addresses the unmet challenges in constructing 1,2-cis glycosidic linkages in 2-deoxy-2-fluorosugars with stereospecificity. It also represents a major advance by enabling stereospecific synthesis of 2-deoxo-2-fluoroarabinofuranosides and 2-deoxy-2-fluororibofuranosides with either an α or a β anomeric configuration, showcasing the versatility of the DGLG approach. It offers by far the only stereospecific construction of these fluorinated glycosides of significant interest in glycoscience research. With the employment of excess donors permitted, this approach can be readily adopted to multistep sequential glycosylations, enabling streamlined and stereospecific access to complex fluorinated glycans.
Keywords: stereospecific glycosylation, 2-deoxy-2-fluoroglycosides, 2-deoxy-2-fluorofuranosides, SN2 glycosylation, stereochemical inversion
Graphical Abstract

Introduction
Fluorinated sugars1–4 have attracted considerable interest in medicinal chemistry (Scheme 1a)5–7 and are also employed as positron emission tomography (PET) tracers8 and probes in chemical biology research.9 The replacement of a 2-OH group in a sugar ring with a fluorine in 2-deoxy-2-fluoroglucosides affords enhanced stability to the glycosidic bond, enhances anomeric effect, increase lipophilicity, alter binding affinity, and improves pharmacokinetics without significantly affecting sterics and H-bond accepting capacity.7 Various synthetic advances have been achieved in installing fluorine in monosaccharides,1,10–13 but stereoselective glycosylation employing fluorinated donors and especially the 2-deoxy-2-fluoroglucosyl ones remains challenging and demands innovative solutions.
Scheme 1 |.

(a) Fluorinated sugars: prior stereoselective synthesis and our design.
The Gilmour group achieved fluorine-directed synthesis of 1,2-trans 2-deoxy-2-fluoropyranosides with moderate to excellent selectivities and mostly moderate yields (Scheme 1b1).14–17 For the synthesis of more challenging 1,2-cis α−2-deoxy-2-fluoropyranosides, in 2021 the Nguyen lab reported a phenanthroline-catalyzed stereoselective synthesis (Scheme 1b2).18 Despite the fact that this method represents an important breakthrough, the α/β ratio in most cases was found to be no more than 13:1, and yields were mostly no more than 85%. Furthermore, the reaction takes 24 h, and 3 equiv of acceptors are used. On the other hand, stereoselective reactions of 2-deoxy-2-fluorofuranosyl donors are seldom studied. Among the three recently reported cases (Scheme 1c), one led to the highly selective formation of an α−2-deoxy-2-fluoroxyloside 1,19 but the other two afforded 2-deoxy-2-fluoroarabinoside 2 with β/α ratios of 5/1.19,20 Of importance to note is that in all these prior efforts, excess acceptors (1.2–3 equiv) were employed to enhance yield and increase stereoselectivity. However, this practice is not desirable in sequential glycosylations, where acceptors become increasingly expensive. This is particularly true in automated glycan assembly21 based on solid-phase synthesis, where donors are often used in significant excess. To this end, the need to develop novel strategies for glycosylation of 2-deoxy-2-fluoro donors that are stereospecific, high-yielding, employing donors in excess, and broadly applicable remains unfulfilled. A breakthrough of this nature would, in turn, significantly facilitate access to fluorinated oligosaccharides either via sequential solution-phase or automated solid-phase synthesis and accelerate their applications in biomedical research.22,23
For the past several years, our lab has pursued a directing-group-on-leaving-group (DGLG) strategy for the implementation of a general SN2 glycosylation.24–30 The first two approaches relied on gold catalysis,31–36 but the reactions typically require 24 h due to impeded catalyst turnover, and excess acceptors are employed to improve the reaction rate and yield. Moreover, the scopes remain to be broadened. Our further implementation employs a stoichiometric approach.37 As shown in Scheme 1d, the donor 3 features a chromenone-based leaving group, on which a diisopropylphosphinoyl moiety is installed judiciously as a directing group. With Y = OBn or H, 3 is activated upon a (Coll)2Br+ NTf2−-promoted electrophilic cyclization, affording the activated donor A. This activation is facile and complete in less than 10 min at −40 °C. The desired SN2 glycosylation is realized upon a backend attack at the anomeric center by an acceptor. This attack is directed by the diisopropylphosphinoyl group via the formation of a strong H-bond38 and facilitated by the proper positioning of the directing group in the leaving group via a rigid connection to the sugar ring (highlighted in blue in A). The glycosylation proceeds to completion in dichloromethane (DCM), in 1 h, and at −40 °C and exhibits excellent stereoselectivity in a mostly SN2 fashion. These reaction characteristics are ideally suited for automated synthesis, and the reaction is successfully applied in the construction of challenging 1,2-cis glycosidic linkages in automated glycan assembly.21,37 We surmise that this approach might be amenable to stereospecific synthesis of 2-deoxy-2-fluoropyranosides and 2-deoxy-2-fluorofuranosides. Such a method would enable the incorporation of 2-deoxy-2-fluoro sugars in expedient sequential solution-phase or automated solid-phase oligosaccharide synthesis and thus expand the scope of glycans accessible to nonspecialists for biomedical research. It is, however, not clear to us that replacing a 2-OBn(H) group in the chromen-1-one-based donor 3 (Y = OBn or H) with a more electron-withdrawing fluoro group could be tolerated or not. In addition, the F-directing effect Gilmour14–16 observed could adversely impact the reaction stereoselectivity in the construction of 1,2-cis glycosidic linkages.
Results and Discussion
At the outset, we studied the reaction of the 2-deoxy-2-fluorogalactosyl donor 3a with methyl 2,3,4-tri-O-benzylglucoside (4) (Table 1). 3a was prepared by following the previously reported protocols by installing the polar directing group at the end,37 which permits easy purification. The optimized conditions use 1.5 equiv of 3a, 1.8 equiv of (Coll)2Br+ NTf2, at −40 °C, in anhydrous DCM, and with 4 Å molecular sieves (MS). The reaction proceeded to completion in 1 h and was extremely clean, affording the desired 2F-Gal(α1→6)Glc product 5a in 99% yield and with exclusive α-configuration at the newly formed glycosidic bond (entry 1). This result compares favorably to the reported one (85% yield, α/β = 11:1, 24 h, 3 equiv of acceptor),18 and the reaction conditions—fast reaction (1 h), donor access, resin-suitable solvent (DCM)—should be conducive to automated glycan assembly.21,37 Using lesser amounts of 3a (1.2 equiv) and (Coll)2Br+ NTf2 (1.3 equiv) worked equally well (entry 2). We opted to use higher amounts in the optimal conditions (entry 1) to enhance the tolerance of a broad range of donors/acceptors in achieving excellent yields and acceptor conversion. Increasing the reaction temperature to −20 °C (entry 3) or 0 °C led to decreased α/β selectivities, and solvents known to participate in glycosylation reactions39,40 such as CH3CN (entry 5) and Et2O (entry 6) led to poor conversions, poor yields, and low stereoselectivity.
Table 1 |.
Reaction Conditions Optimization
| ||
|---|---|---|
| Entry | Change from “Standard Conditions” | Resultsa |
| 1 | None | Full conversion; 99% yield (5a); α only; |
| 2 | 1.2 equiv 3a and 1.2 equiv (Coll)2Br+NTf2− was used | Full conversion; 99% yield (5a); α only; |
| 3 | −20 °C, 1 h instead of −40 °C, 1 h | 1.5% 4 left; 96% yield (5a); α/β = 58:1; |
| 4 | 0 °C, 1 h instead of −40 °C, 1 h | 4.5% 4 left; 93% yield (5a); α/β = 18:1; |
| 5 | CH3CN instead of DCM | 67% 4 left; 17% yield (5a); α/β = 4.9:1; |
| 6 | Et2O instead of DCM | 44% 4 left; 14% yield (5a); α/β = 3.5:1; |
Yield and anomeric ratio determined by 1H NMR analysis of the crude reaction mixture. (Coll)2Br+NTf2−: bis(symcollidine)bromine(I) bis(trifluoromethanesulfonyl)imide.
To explore the reaction scope, 3a was reacted smoothly with five additional acceptors, delivering the 2-deoxy-2-fluoropyranosides 5c–5g in ≥90% yield and with complete anomer stereochemistry inversion either after 1 h at −40 °C or after 4 h at −60 °C (Table 2a). Notably, sterically hindered secondary alcohols were readily allowed. In the case of 5g, the acceptor sulfide moiety was compatible with the electrophilic Br reagent under the reaction conditions, and running the reaction at −60 °C resulted in better conversion of the acceptor. In the case of 5b, an acetyl group at the 6-O position replaced the Bn group in 3a and, although disarming, posed no issue.
Table 2 |.
The Scope of 2-Deoxy-2-fluoropyranosides Accessible via the DGLG Approacha
|
Isolated yield reported. For reactions running at −60 °C, 2.0 equiv of donor and 2.4 equiv of (Coll)2Br+ NTf2− were used.
8% of the acceptor remained.
This SN2 glycosylation with a β−3,4,6-tris-O-benzyl-2-deoxy-2-fluoroglucosyl donor also worked smoothly, delivering the fluorinated diglucosides 5h–5l in yields ranging from 86% to 99% and with complete α-configuration (Table 2b). Both primary (5h–5i) and secondary acceptors (5j–5l) were tolerated. In comparison, 5j was synthesized previously in 68% yield and with α/β = 10:1.18 Extending the pyranosyl donor scope revealed that a β−2,6-dideoxy-2-fluoroglucosyl donor also underwent complete SN2 glycosylation with both primary and secondary acceptors to deliver 5m–5s with an α-anomeric configuration exclusively and in 80%–99% yields (Table 2c).
Of note is that the α configurations of these products were established either by comparison to a literature report18 and/or by measuring their 1JC1-H1 values, which ranged from 170 to 176 Hz.41 Examples of crude 1H nuclear magnetic resonance (NMR) spectra are provided in the Supporting Information to support the exclusive α-selectivity in these glycosylation reactions.
Our attempts to study the synthesis of the β-counterparts of the pyranosides in Table 2 were thwarted by the difficulty of accessing the requisite pure α-donors.
We then examined the scantily studied 2-deoxy-2-fluorofuranosides (Table 3). We first employed a 2-deoxy-2-fluoroarabinofuranosyl donor, that is, 7. Both the α- and β-anomers of this donor, obtained in pure form, were reacted with an identical set of six acceptors, and the results are shown in Table 3a,b, respectively. In comparison to the reported synthesis of the arabinofuranoside 2 (α/β ratio of 1/5, Scheme 1c),19,20 β−2 was synthesized from α−7 in 99% yield and stereospecifically. Conversely, α−2 was synthesized from β−7 with exclusive stereoinversion and in nearly quantitative yield. The absence of the other anomer in these two reactions was evident from the crude 1H NMR spectra (Figure 1) and highlighted the extraordinary stereocontrol rendered by our chemistry. The 1H NMR spectra of β−2 and α−2 were identical to the reported major isomer and the minor isomer, respectively,19,20 which supported our structural assignments. Moreover, our detailed spectroscopic analysis confirmed that the 1JC1-H1 values—175 Hz for β−2 and 176 Hz for α−2—were not useful for assigning anomeric configuration of furanosides, but the 3JH1-F2 values—<1 Hz for β−2 possessing trans H1-F2 and 12.1 Hz for α−2 possessing cis H1-F2—are drastically different and might be employed to assign anomeric configurations of 2-deoxy-2-fluorofuranosides. The reaction of α−7 with five additional acceptors afforded additional 1,2-cis arabinofuranosides β−8a–β−8e with complete stereochemical inversion at the anomeric center and in mostly excellent yields (Table 3a). In the challenging cases employing secondary acceptors (β−8c–β−8e), the reactions proceeded smoothly at −60 °C. Not surprisingly, the reactions of β−7 were also highly efficient and stereospecific, affording the opposing 1,2-trans 2-deoxy-2-fluoroarabinofuranosides α−8a–α−8e in ≥91% yield and with complete stereochemical inversion (Table 3b). The configuration assignments of these anomeric pairs were based on the SN2 nature of the glycosylation and substantiated by the consistently contrasting 3JH1-F2 values, that is, <1 Hz for β−8 possessing trans H1-F2 and 11.4–12.8 Hz for α−8 possessing cis H1-F2.
Table 3 |.
The Scope of 2-Deoxy-2-fluorofuranosides Accessible via the DGLG Approacha
|
Reaction conditions: 1.5 equiv of donor, 1.0 equiv of acceptor, 1.8 equiv of (Coll)2Br+ NTf2−, 4 Å MS in anhydrous DCM, at −40 °C, and 1 h. For reactions at −60 °C, 2.0 equiv of donor and 2.4 equiv of (Coll)2Br+ NTf2− were used, and the reaction time was 4 h. Isolated yield was reported.
Figure 1 |.

NMR evidence of the reaction stereospecificity.
Furthermore, α- or β−2-deoxy-2-fluororibosyl donor 9 also reacted smoothly with primary acceptors to deliver α−10a–α−10c (Table 3c) and β−10b and β−10c (Table 3d), respectively, in good to excellent yields and with complete anomeric configuration inversion. The reaction of β−9 with (−)-menthol, a secondary alcohol, was also successful, delivering α−10d in a nearly perfect outcome (Table 3c). However, with sugar-based secondary acceptors, the reactions experienced incomplete conversions and hence low yields (≤65%), despite exhibiting complete inversion of anomeric configurations. The anomeric configurations of these furanosides were established by a combination of NMR spectroscopy and the assumption of the SN2 chemistry. We noted that α−10 possessing 1,2-trans H1-F2 exhibited substantially smaller 3JH1-F2 values (3.1–5.5 Hz) than β−10 possessing 1,2-cis H1-F2 (10.6 and 11.0 Hz), offering further support to the expectation that this coupling constant can be used to assign the anomeric configurations of 2-deoxy-2-fluorofuranosides, with a value of >10 Hz likely pointing to a 1,2-cis H1-F2 relationship. This conjecture remains to be verified with the other 2-deoxy-2-fluorofuranosides.
To demonstrate the synthetic utility of this chemistry, we synthesized two fluorinated oligosaccharides, that is, 12 and 16 (Scheme 2). For the synthesis of the pentasaccharide 12 (Scheme 2a), we used the acceptor tetrasaccharide 11, which was previously prepared32 for the synthesis of an α-glucan pentasaccharide repeating unit of an immunostimulating glycan isolated from Aconitum Carmichaeli.42 Its reaction with the 6-O-Ac donor 3b proceeded smoothly to afford the desired pentasaccharide 12—a 2-deoxy-2-fluorogalactosyl analog of the natural pentasaccharide fragment—in 93% yield and with exclusive α-selectivity. In the synthesis of the tetrasaccharide 16 (Scheme 2b) possessing three 1,2-cis 2-deoxy-2-fluoro glycosidic linkages, the secondary acceptor methyl 2,3,6-tri-O-benzylglucoside (13) was subjected to the two-step sequence—glycosylation with the donor 3b and basic hydrolysis—to deliver the disaccharide 14 in 83% overall yield and with complete α-configuration. This sequence was repeated to afford the trisaccharide 15 with similar outcomes. In both glycosylation steps, 1.2 equiv of the donor 3b were sufficient. The final tetrasaccharide 16 was prepared from 15 in 95% yield via an SN2 glycosylation with a 2,6-dideoxy-2-fluoroglucosyl donor. Notable in this synthetic sequence was the straightforward nature of the glycosylation steps. The entire synthesis was completed in a few days without any issues, and the absence of anomeric mixtures allowed silica gel column purification to be performed with ease.
Scheme 2 |.

Synthesis of fluorinated oligosaccharides.
To probe the directing effect of the donor phosphinoyl group, we recorded the 1H NMR spectra of acceptor 4 at various temperatures using CD2Cl2 as the solvent.43 At a concentration of 0.060 M, acceptor 4 displayed a clearly resolved OH triplet, with δ(OH) appearing in a narrow range of 1.65–1.90 ppm (Figure 2a). As the temperature decreased from 25 to −40 °C, the OH signal exhibited a slight but consistent downfield shift. Upon mixing acceptor 4 (0.060 M) with donor 3a (0.066 M), the OH resonance underwent a much more pronounced and increasing downfield shift as the temperature decreased (Figure 2b). A Δδ(OH) of 1.64 ppm was observed at −40 °C, indicating a strong hydrogen bond between the hydroxyl group of 4 and the phosphinoyl group of 3a under the glycosylation conditions and firmly supporting the role of such an interaction in achieving the SN2 glycosylation.
Figure 2 |.

Partial 1H NMR spectra in CD2Cl2 in variable-temperature NMR studies of acceptor 4 with or without donor 3a.
Conclusion
In conclusion, we have realized stereospecific synthesis of 2-deoxy-2-fluoroglycosides via a DGLG strategy. This SN2 glycosylation chemistry was successfully applied to the synthesis of α−2-deoxy-2-fluoroglucose, α−2-deoxy-2-fluorogalactose, α−2,6-dideoxy-2-fluoro-glucose, α/β−2-deoxy-2-fluoroarabinose, and α/β−2-deoxy-2-fluororibose, delivering high yields and unprecedented complete stereochemical inversion at the anomeric center. These results were achieved despite the presence of a neighboring deactivating fluoro group and the potential adverse fluorine directing effect. The efficient and straightforward syntheses of complex fluorinated oligosaccharides highlight the synthetic utility of this chemistry. Despite the elaborate nature of the designed leaving group, the reaction characteristics—short reaction time (typically 1 h), resin-suitable solvent (DCM), donor access, and stereospecificity—make it versatile in sequential glycosylations and conducive to solid-phase synthesis and automated glycan assembly, in which the cost of installing such a leaving group could be tolerated. We will explore the utility of our chemistry in this direction in the future.
Supplementary Material
Supporting Information is available and includes experimental procedures and NMR spectra.
Funding Information
The authors gratefully acknowledge the financial support of the National Science Foundation (NSF CHE-2247934) and the National Institute of General Medical Science (NIGMS R35GM139640). NSF MRI-1920299 enabled us to acquire the Bruker 500 MHz and 400 MHz NMR instruments, and the HR-MS analysis was performed by a LS-MS instrument funded by the office of Navy Research Award N00014-23-2197.
Footnotes
Conflict of Interest
The authors declare no competing financial interest.
References
- 1.Huonnic K; Linclau B The Synthesis and Glycoside Formation of Polyfluorinated Carbohydrates. Chem. Rev 2022, 122, 15503–15602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rundell SR; Wagar ZL; Meints LM; Olson CD; O’Neill MK; Piligian BF; Poston AW; Hood RJ; Woodruff PJ; Swarts BM Deoxyfluoro-d-trehalose (FDTre) Analogues as Potential PET Probes for Imaging Mycobacterial Infection. Org. Biomol. Chem 2016, 14, 8598–8609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Büll C; Boltje TJ; Wassink M; de Graaf AMA; van Delft FL; den Brok MH; Adema GJ Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth. Mol. Cancer Ther 2013, 12, 1935–1946. [DOI] [PubMed] [Google Scholar]
- 4.Sadurní A; Kehr G; Ahlqvist M; Wernevik J; Sjögren HP; Kankkonen C; Knerr L; Gilmour R Fluorine-Directed Glycosylation Enables the Stereocontrolled Synthesis of Selective SGLT2 Inhibitors for Type II Diabetes. Chem. – Eur. J 2018, 24, 2832–2836. [DOI] [PubMed] [Google Scholar]
- 5.Wei X; Wang P; Liu F; Ye X; Xiong D Drug Discovery Based on Fluorine-Containing Glycomimetics. Molecules 2023, 28, 6641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tamburrini A; Colombo C; Bernardi A Design and Synthesis of Glycomimetics: Recent Advances. Med. Res. Rev 2020, 40, 495–531. [DOI] [PubMed] [Google Scholar]
- 7.Hevey R The Role of Fluorine in Glycomimetic Drug Design. Chem. – Eur. J 2021, 27, 2240–2253. [DOI] [PubMed] [Google Scholar]
- 8.Shinde SS; Maschauer S; Prante O Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects. Pharmaceuticals 2021, 14, 1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Linclau B; Ardá A; Reichardt N-C; Sollogoub M; Unione L; Vincent SP; Jiménez-Barbero J Fluorinated Carbohydrates as Chemical Probes for Molecular Recognition Studies. Current Status and Perspectives. Chem. Soc. Rev 2020, 49, 3863–3888. [DOI] [PubMed] [Google Scholar]
- 10.Albert M; Dax K; Ortner J A Novel Direct Route to 2-Deoxy-2-fluoro-aldoses and Their Corresponding Derivatives. Tetrahedron 1998, 54, 4839–4848. [Google Scholar]
- 11.Vincent SP; Burkart MD; Tsai C-Y; Zhang Z; Wong C-H Electrophilic Fluorination–Nucleophilic Addition Reaction Mediated by Selectfluor: Mechanistic Studies and New Applications. J. Org. Chem 1999, 64, 5264–5279. [DOI] [PubMed] [Google Scholar]
- 12.Mtashobya L; Quiquempoix L; Linclau B The Synthesis of Mono- and Difluorinated 2,3-Dideoxy-d-glucopyranoses. J. Fluorine Chem 2015, 171, 92–96. [Google Scholar]
- 13.Denavit V; Lainé D; St-Gelais J; Johnson PA; Giguère D A Chiron Approach Towards the Stereoselective Synthesis of Polyfluorinated Carbohydrates. Nat. Commun 2018, 9, 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bucher C; Gilmour R Fluorine-Directed Glycosylation. Angew. Chem. Int. Ed 2010, 49, 8724–8728. [Google Scholar]
- 15.Durantie E; Bucher C; Gilmour R Fluorine-Directed β-Galactosylation: Chemical Glycosylation Development by Molecular Editing. Chem. – Eur. J 2012, 18, 8208–8215. [DOI] [PubMed] [Google Scholar]
- 16.Aiguabella N; Holland MC; Gilmour R Fluorine-Directed 1,2-Trans Glycosylation of Rare Sugars. Org. Biomol. Chem 2016, 14, 5534–5538. [DOI] [PubMed] [Google Scholar]
- 17.Siebold K; Chikunova E; Lorz N; Jordan C; Gossert AD; Gilmour R Fluoro-Fucosylation Enables the Interrogation of the Lea-LecB Interaction by BioNMR Spectroscopy. Angew. Chem. Int. Ed 2025, 64, e202423782. [Google Scholar]
- 18.DeMent PM; Liu C; Wakpal J; Schaugaard RN; Schlegel HB; Nguyen HM Phenanthroline-Catalyzed Stereoselective Formation of α−1,2-cis 2-Deoxy-2-Fluoro Glycosides. ACS Catal 2021, 11, 2108–2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Xu H; Schaugaard RN; Li J; Schlegel HB; Nguyen HM Stereoselective 1,2-cis Furanosylations Catalyzed by Phenanthroline. J. Am. Chem. Soc 2022, 144, 7441–7456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mayfield AB; Metternich JB; Trotta AH; Jacobsen EN Stereospecific Furanosylations Catalyzed by Bisthiourea Hydrogen-Bond Donors. J. Am. Chem. Soc 2020, 142, 4061–4069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Guberman M; Seeberger PH Automated Glycan Assembly: A Perspective. J. Am. Chem. Soc 2019, 141, 5581–5592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lo H-J; Krasnova L; Dey S; Cheng T; Liu H; Tsai T-I; Wu KB; Wu C-Y; Wong C-H Synthesis of Sialidase-Resistant Oligosaccharide and Antibody Glycoform Containing α2,6-Linked 3Fax-Neu5Ac. J. Am. Chem. Soc 2019, 141, 6484–6488. [DOI] [PubMed] [Google Scholar]
- 23.Jordan C; Hayashi T; Löbbert A; Fan J; Teschers CS; Siebold K; Aufiero M; Pape F; Campbell E; Axer A; Bussmann K; Bergander K; Köhnke J; Gossert AD; Gilmour R Probing the Origin of Affinity in the GM1-Cholera Toxin Complex Through Site-Selective Editing with Fluorine. ACS Cent. Sci 2024, 10, 1481–1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Park Y; Harper KC; Kuhl N; Kwan EE; Liu RY; Jacobsen EN Macrocyclic Bis-Thioureas Catalyze Stereospecific Glycosylation Reactions. Science 2017, 355, 162–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Nguyen HM; Yu F; Li J; DeMent PM; Tu Y-J; Schlegel HB Phenanthroline-Catalyzed Stereoretentive Glycosylations. Angew. Chem. Int. Ed 2019, 58, 6957–6961. [Google Scholar]
- 26.Adero PO; Amarasekara H; Wen P; Bohé L; Crich D The Experimental Evidence in Support of Glycosylation Mechanisms at the SN1–SN2 Interface. Chem. Rev 2018, 118, 8242–8284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zhuo M-H; Wilbur DJ; Kwan EE; Bennett CS Matching Glycosyl Donor Reactivity to Sulfonate Leaving Group Ability Permits SN2 Glycosylations. J. Am. Chem. Soc 2019, 141, 16743–16754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Deng L-F; Wang Y; Xu S; Shen A; Zhu H; Zhang S; Zhang X; Niu D Palladium Catalysis Enables Cross-Coupling–Like SN2-Glycosylation of Phenols. Science 2023, 382, 928–935. [DOI] [PubMed] [Google Scholar]
- 29.Zhu Y; Evans PA Palladium-Catalyzed SN2 Glycosylation of Phenols. Sci. China Chem 2024, 67, 1037–1038. [Google Scholar]
- 30.Takeuchi H; Fujimori Y; Ueda Y; Shibayama H; Nagaishi M; Yoshimura T; Sasamori T; Tokitoh N; Furuta T; Kawabata T Solvent-Dependent Mechanism and Stereochemistry of Mitsunobu Glycosylation with Unprotected Pyranoses. Org. Lett 2020, 22, 4754–4759. [DOI] [PubMed] [Google Scholar]
- 31.Ma X; Zheng Z; Fu Y; Zhu X; Liu P; Zhang LA “Traceless” Directing Group Enables Catalytic SN2 Glycosylation Toward 1,2-cis-Glycopyranosides. J. Am. Chem. Soc 2021, 143, 11908–11913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ma X; Zhang Y; Zhu X; Wei Y; Zhang L Directed SN2 Glycosylation Employing an Amide-Functionalized 1-Naphthoate Platform Featuring a Selectivity-Safeguarding Mechanism. J. Am. Chem. Soc 2023, 145, 11921–11926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ma X; Zhang Y; Zhu X; Zhang L An SN2-Type Strategy Toward 1, 2-cis-Furanosides. CCS Chem 2022, 4, 3677–3685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zhang Y; Ma X; Zhang L Highly Stereoselective Synthesis of 2-Azido-2-Deoxyglycosides via Gold-Catalyzed SN2 Glycosylation. CCS Chem 2023, 5, 2799–2807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Issa JP; Bennett CS A Reagent-Controlled SN2-Glycosylation for the Direct Synthesis of β-Linked 2-Deoxy-Sugars. J. Am. Chem. Soc 2014, 136, 5740–5744. [DOI] [PubMed] [Google Scholar]
- 36.Yu B Gold(I)-Catalyzed Glycosylation with Glycosyl o-Alkynylbenzoates as Donors. Acc. Chem. Res 2018, 51, 507–516. [DOI] [PubMed] [Google Scholar]
- 37.Zhang Q; Flodén NJ; Zhang Y; Yang J; Kohnke P; Danglad-Flores J; Sletten ET; Seeberger PH; Zhang L A Broadly Applicable Stereospecific Glycosylation. Nat. Synth 2025. DOI: 10.1038/s44160-025-00846-z [DOI] [Google Scholar]
- 38.Laurence C; Brameld KA; Graton J; Le Questel J-Y; Renault E The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists. J. Med. Chem 2009, 52, 4073–4086. [DOI] [PubMed] [Google Scholar]
- 39.Mong K-KT; Nokami T; Tran NTT; Nhi PB Solvent Effect on Glycosylation. In Selective Glycosylations: Synthetic Methods and Catalysts; Bennett CS, Ed.; Wiley-VCH: Weinheim, Germany, 2017; pp 59–77. [Google Scholar]
- 40.Kafle A; Liu J; Cui L Controlling the Stereoselectivity of Glycosylation via Solvent Effects. Can. J. Chem 2016, 94, 894–901. [Google Scholar]
- 41.Bock K; Pedersen C A Study of 13CH Coupling Constants in Hexopyranoses. J. Chem. Soc. Perkin Trans 2 1974, 293–297. DOI: 10.1039/P29740000293 [DOI] [Google Scholar]
- 42.Zhao C; Li M; Luo Y; Wu W Isolation and Structural Characterization of an Immunostimulating Polysaccharide from Fuzi, Aconitum carmichaeli. Carbohydr. Res 2006, 341, 485–491. [DOI] [PubMed] [Google Scholar]
- 43.Liu X; Lin Y; Peng W; Zhang Z; Gao L; Zhou Y; Song Z; Wang Y; Xu P; Yu B; Sun H; Xie W; Li W Direct Synthesis of 2,6-Dideoxy-β-glycosides and β-Rhamnosides with a Stereodirecting 2-(Diphenylphosphinoyl)acetyl Group. Angew. Chem. Int. Ed 2022, 61, e202206128. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
